Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

• Main Authors: Lorie Benning (Author), Andrea Mantsios (Author), Deanna Kerrigan (Author), Jenell S. Coleman (Author), Elizabeth Golub (Author), Oni Blackstock (Author), Deborah Konkle-Parker (Author), Morgan Philbin (Author), Anandi Sheth (Author), Adaora A. Adimora (Author), Mardge H. Cohen (Author), Dominika Seidman (Author), Joel Milam (Author), Seble G. Kassaye (Author), Tonya Taylor (Author), Miranda Murray (Author)
• Format: Book
• Published: BMC, 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Long-acting (LA) injectable antiretroviral therapy (ART) has been found non-inferior to daily oral ART in Phase 3 trials. LA ART may address key barriers to oral ART adherence and be preferable to daily pills for some people living with HIV. To date, women have been less represen...